- Retrospective Tissue Registry
- NeoAdjuvant Breast Registry Platform
- Genetic Testing Registry Platform
- Device Outcomes and Impact Registry Platform
TME Research is an extension of the TME mission to improve quality and access to emerging technologies and best practices in breast cancer prevention, diagnosis, treatment and patient care.
We are a partnership of community leading practitioners and experienced researchers who design, execute and drive enrollment in Registries that collect the real world experience and data that support the adoption of emerging technologies.
Extensive experience in publication helps us turn raw data into insight, analysis, publications and presentation.
TME Research registries provide an opportunity for research partnerships with industry.
These Registries target areas of significant interest in breast cancer with the aim of supporting development, understanding and adoption of emerging technologies. Jointly funded by TME and industry.
TME designs the Registry, creates the electronic tools for collecting and providing you access to the data, and trains and supports implementation in your practice.